コンテンツへスキップ
Merck

Evidence of a Viable Pool of Stem Cells within Human Osteoarthritic Cartilage.

Cartilage (2015-06-13)
Larissa Nelson, Helen E McCarthy, John Fairclough, Rebecca Williams, Charles W Archer
要旨

Osteoarthritis (OA) is a debilitating disease affecting more than 4 million people in the United Kingdom. Despite its prevalence, there is no successful cell-based therapy currently used to treat patients whose cartilage is deemed irrecoverable. The present study aimed to isolate stem cells from tibial plateaux cartilage obtained from patients who underwent total knee replacements for OA and investigate their stem cell characteristics. Clonally derived cell lines were selected using a differential adhesion assay to fibronectin and expanded in monolayer culture. Colony forming efficiencies and growth kinetics were investigated. The potential for tri-lineage differentiation into chondrogenic, osteogenic, and adipogenic phenotypes were analyzed using histological stains, immunocytochemistry, and reverse transcriptase polymerase chain reaction. Colony forming cells were successfully isolated from osteoarthritic cartilage and extensively expanded in monolayer culture. Colony forming efficiencies were consistently below 0.1%. Clonal cell lines were expanded beyond 40 population doublings but disparities were observed in the number of population doublings per day. Clonally derived cell lines also demonstrated in vitro multilineage potential via successful differentiation into chondrogenic, osteogenic, and adipogenic lineages. However, variation in the degree of differentiation was observed between these clonal cell lines. A viable pool of cells with stem cell characteristics have been identified within human osteoarthritic cartilage. Variation in the degree of differentiation suggests the possibility of further subpopulations of cells. The identification of this stem cell population highlights the reparative potential of these cells in osteoarthritic cartilage, which could be further exploited to aid the field of regenerative medicine.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
デキサメタゾン, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
L-グルタミン, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-アスコルビン酸, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-アスコルビン酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
L-アスコルビン酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
L-アスコルビン酸, 99%
Sigma-Aldrich
L-アスコルビン酸, reagent grade, crystalline
Supelco
アスコルビン酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-グルタミン, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
セレン, powder, −100 mesh, 99.99% trace metals basis
Sigma-Aldrich
デキサメタゾン, ≥98% (HPLC), powder
USP
アスコルビン酸, United States Pharmacopeia (USP) Reference Standard
SAFC
L-グルタミン
Sigma-Aldrich
HEPES緩衝液, 1 M in H2O
Sigma-Aldrich
セレン, powder, −100 mesh, ≥99.5% trace metals basis
Sigma-Aldrich
モノクロナール抗コラーゲン, I型 マウス宿主抗体, clone COL-1, ascites fluid
Sigma-Aldrich
L-アスコルビン酸, ACS reagent, ≥99%
Sigma-Aldrich
HEPES, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
3,3′-ジアミノベンジジン, 97%
Supelco
L-アスコルビン酸, analytical standard
Sigma-Aldrich
L-(−)-グルコース, ≥99%
Sigma-Aldrich
L-アスコルビン酸, meets USP testing specifications
Sigma-Aldrich
L-アスコルビン酸, reagent grade
Supelco
デキサメタゾン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
デキサメタゾン, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
L-グルタミン, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
HEPES, BioXtra, suitable for mouse embryo cell culture, ≥99.5% (titration)
Sigma-Aldrich
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)